EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Linking sORFs and microproteins in hematological malignancies: current update on origin, function and clinical implications

Aaradhana Joshi, Parminder Kaur, Sargeet Kaur, Prateek Bhatia, Minu Singh iD

Blood Research · 2026-12 · 61 (1)

DOI: 10.1007/s44313-026-00184-9 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Blood Research, online erschienen am 11.11.2026. Verfasst von Aaradhana Joshi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Hematology Oncology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India. Die Arbeit nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Advances in integrated translatomics and proteomics techniques have successfully identified the hidden layer of the microproteome that has historically been regarded as non-coding. Investigations into the involvement of microproteins in hematological malignancies may help address the key gaps that persist despite extensive genomic and transcriptomic profiling. Many blood cancers display extensive clonal heterogeneity, dynamic evolution, and limited actionable mutations. Consequently, mutation-centric approaches are insufficient to fully elucidate disease behavior and identify novel treatment methods. Understanding the role of microproteins may help clarify the relationship between aberrant non-coding RNA expression and observed phenotypes in malignant cells, by finding the direct key contributors to signaling, metabolic rewiring, and epigenetic regulation. These tiny molecules may uncover an unexplored reservoir of disease regulators and potential antigenic targets for immunotherapy. Antigenic microproteins, arising from unconventional coding regions such as ncRNA transcripts, may elicit T-cell responses and represent a previously unrecognized class of immunogenic molecules with therapeutic relevance. This review highlights the need for exploration of the role of microproteins in pathobiology of hematological malignancies and provides a framework to support future studies evaluating the immunogenic potential of microproteins as antigenic targets.

Schlagwörter

Stichwörter der Autor:innen

Acute myeloid leukemiaHematological malignanciesImmunotherapeutic targetsMicroproteinsNon-canonical translationNon-coding RNAProteogenomics

Autor:innen und Institutionen

  • Hematology Oncology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Hematology Oncology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India. meenusingh.dr@gmail.com.

ORCID-Profile: Minu Singh

Zitieren

APA

Joshi, A., Kaur, P., Kaur, S., Bhatia, P., & Singh, M. (2026). Linking sORFs and microproteins in hematological malignancies: current update on origin, function and clinical implications. Blood Research, 61(1). https://doi.org/10.1007/s44313-026-00184-9

Vancouver

Joshi A, Kaur P, Kaur S, Bhatia P, Singh M. Linking sORFs and microproteins in hematological malignancies: current update on origin, function and clinical implications. Blood Research. 2026;61(1). doi:10.1007/s44313-026-00184-9

BibTeX
@article{Joshi2026,
  author = {Joshi, Aaradhana and Kaur, Parminder and Kaur, Sargeet and Bhatia, Prateek and Singh, Minu},
  title = {Linking sORFs and microproteins in hematological malignancies: current update on origin, function and clinical implications},
  journal = {Blood Research},
  year = {2026},
  volume = {61},
  number = {1},
  doi = {10.1007/s44313-026-00184-9}
}
Kostenlos starten →